OncoTAb
ORDER NOWSEEKING PHYSICIAN COLLABORATION
  • HOME
  • ABOUT
  • FAQ
  • SCIENCE & TECHNOLOGY
  • FIND A PHYSICIAN
  • NEWS
  • BLOG
  • HONOR WALL
  • CONTACT
  • PATIENT LOGIN
  • Shop0
  • lady with slide
    Concerned About Breast Cancer?
    OncoTAb's cutting edge patented technology was used to develop a blood test, Agkura™ Personal Score, which aids breast cancer detection in women with dense breast tissue.

Patient Portal

Login

Lost your password?

Your Cart

Get Your

Agkura™ Personal Score

Click Here
RSS Breast Cancer News
  • Can KRAS Positive Colorectal and Lung Cancer Finally be Targeted?
    New precision medicines effectively target KRAS mutations in lung, colon, and other cancers.
  • Ask the Experts About Circulating Tumor DNA in the Management of Cancer
    Ask the Experts About Circulating Tumor DNA (ctDNA) in the Management of Cancer
  • FDA Grants Fast Track Designation to STRO-002 for Advanced Ovarian Cancer
    Learn about the STRO-002 Antibody-drug conjugate in Ovarian Cancer
  • Dacogen Effective in Advanced Myeloproliferative Neoplasms
    Dacogen Effective in Advanced Phases of MPN
  • Jakafi Does'nt Increase Risk of New Cancers
    Study suggests Jakafi not associated with increase in significant secondary malignancies.
  • TILs + Opdivo Produce Remissions in Advanced Lung Cancer
    Could TILs represent the next advance in the treatment of lung cancer?
  • Driving advances in breast cancer surgery
    The latest advances in novel surgical techniques which are improving outcomes for breast cancer patients.
  • 5 Ways to Support Your Mental Wellness During Radiation Therapy
    Activity, Nutrition and Mental Health-Essential for Cancer Treatment Success
  • Does Preoperative Immunotherapy Improve Treatment of Locally Advanced Rectal Cancer?
    Immunotherapy May Improve Treatment of Rectal Cancer
  • Ipatasertib Precision Cancer Medicine for Prostate Cancer
    According to the results of a recent clinical study aggressive prostate cancers may be treated more effectively by combining an existing targeted medicine, Zytiga (abiraterone) with a new experimental drug to block two of cancer’s growth signals at once. The combination delayed prostate cancers ...
OncoTAb logo

NEWSLETTER

SOCIAL MEDIA

LINKS

AreYouDense.org
UnderstandBreastDensity.org

ADDRESS

243 Bioinformatics Bldg
9201 University City Blvd
Charlotte, NC 28223

PHONE

1-855-ONCOTAB (855-662-6822)

EMAIL

customerservice@oncotab.com

© 2019 COPYRIGHT OncoTAb, Inc. ALL RIGHTS RESERVED.

PRIVACY POLICY | TERMS OF USE

Not available for purchase by residents of CA, FL, MD, PA and NY.

Not available for purchase by residents of CA, NY, NJ, RI and MA.